← Company directoryNYSE American · SEC EDGAR
Matinas BioPharma Holdings, Inc.
MTNBA primary-source company identity page built for fast discovery, filing verification and consistent financial research.
SHARE PRICE · INDICATIVE——
A recent price could not be verified. Check the exchange before trading.
ANALYSIS ROUTE
Four checks before any decision
Business model
Understand how the company earns and where demand originates.
Revenue and margin
Compare equivalent periods; separate growth from profitability.
Debt and cash flow
Test balance-sheet resilience and cash conversion.
Valuation and risk
Use sector peers, scenarios and explicit risk limits.
Company calendar
Matinas BioPharma 1-for-15 reverse split
Matinas BioPharma's 1-for-15 reverse split took effect on September 28, 2026 at 12:01 AM EDT / 7:01 AM Istanbul, with MTNB shares expected to begin split-adjusted trading at the NYSE American open that day. The ticker remains MTNB, the new CUSIP is 576810402, and fractional entitlements receive proportional cash payments. The action is intended to maintain the NYSE American listing, but continued listing is not assured.
SEC EDGAR · Matinas BioPharma ↗More NYSE American records
Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.
REPXRiley Exploration Permian, Inc.NYSE American · SEC→GAUGaliano Gold Inc.NYSE American · SEC→GROYGold Royalty Corp.NYSE American · SEC→NGNOVAGOLD Resources Inc.NYSE American · SEC→FAXabrdn Asia-Pacific Income Fund, Inc.NYSE American · NYSE American→EADAllspring Income Opportunities FundNYSE American · NYSE American→ERCAllspring Multi-Sector Income FundNYSE American · NYSE American→ERHAllspring Utilities and High Income FundNYSE American · NYSE American→
DATA STATUS
Open official filings ↗Checking SEC financial statements
A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.